Stifel Maintains DarioHealth(DRIO.US) With Buy Rating, Cuts Target Price to $2
DarioHealth Is Maintained at Buy by Stifel
DarioHealth Analyst Ratings
TD Cowen Maintains DarioHealth(DRIO.US) With Hold Rating, Maintains Target Price $1
DarioHealth's Balanced Outlook: Promising Growth Amidst Uncertainties Justifies Hold Rating
TD Cowen Downgrades DarioHealth to Hold From Buy, Adjusts Price Target to $1 From $2
TD Cowen Downgrades DarioHealth(DRIO.US) to Hold Rating, Cuts Target Price to $1
TD Cowen Maintains DarioHealth(DRIO.US) With Buy Rating, Cuts Target Price to $2
TD Cowen Maintains DarioHealth(DRIO.US) With Buy Rating, Cuts Target Price to $3
DarioHealth Buy Rating Affirmed: Strategic Growth and Path to Profitability
Press Release: DarioHealth Reports Second Quarter 2024 Financial and Operating Results
Analysts Are Bullish on Top Healthcare Stocks: DarioHealth (DRIO), Moderna (MRNA)
DarioHealth Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Staar Surgical (STAA), DarioHealth (DRIO) and Accelerate Diagnostics (AXDX)
Analysts Are Bullish on Top Healthcare Stocks: DarioHealth (DRIO), United Therapeutics (UTHR)
Analysts Offer Insights on Healthcare Companies: Outset Medical (OM), Exact Sciences (EXAS) and DarioHealth (DRIO)
DarioHealth (DRIO) Gets a Buy From Stifel Nicolaus
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bioxcel Therapeutics (BTAI) and DarioHealth (DRIO)
LifeSci Capital Keeps Their Buy Rating on DarioHealth (DRIO)
DarioHealth Analyst Ratings